Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation

  • Demosthenes G. Katritsis
  • , Demosthenes B. Panagiotakos
  • , Evangelia Karvouni
  • , Eleftherios Giazitzoglou
  • , Socrates Korovesis
  • , George Paxinos
  • , Constantine E. Anagnostopoulos
  • , A. John Camm

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Abstract

Ninety patients who underwent cardioversion of persistent atrial fibrillation (AF) were randomized to bisoprolol 5 to 10 mg once daily or carvedilol 12.5 to 25 mg twice daily. Using intention-to-treat analysis, 23 patients (46%) in the bisoprolol group and 17 patients (32%) in the carvedilol group relapsed into AF during the 1 year of total follow-up (p = 0.486). Patients treated with carvedilol had a 14% (hazard ratio 0.86) lower risk of relapse of AF compared with patients in the bisoprolol group, although results were statistically insignificant (p = 0.661) after controlling for patient age, gender, baseline heart rate, and left atrial diameter.

Original languageEnglish
Pages (from-to)1116-1119
Number of pages4
JournalAmerican Journal of Cardiology
Volume92
Issue number9
DOIs
StatePublished - 1 Nov 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation'. Together they form a unique fingerprint.

Cite this